Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-7mvgfcPhase 1Not yet recruiting
Phase 1, randomised, double-blind trial of human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by ICF. Primary endpoints: Pharmacokinetics of regular human insulin and Pharmacodynamics of regular human insulin. Planned start Jul 2018; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-7mvgfc.